Search bioRxivSearch

Biology subjects

Nonaka, T.

Publications and source records attributed to Nonaka, T..

2 recordsLinked to original sources

Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway

Pathologic roles for innate immunity in neurologic disorders are well-described, but protective aspects of the immune response are less understood. Dectin-1, a C-type lectin receptor (CLR), is largely known to induce inflammation. However, we found that Dectin-1 is protective in experimental autoimmune encephalomyelitis (EAE), while its canonical signaling mediator, Card9, promotes the disease. Notably, Dectin-1 does not respond to heat-killed Mycobacteria, an adjuvant to induce EAE. Myeloid cells mediate the protective function of Dectin-1 in EAE and upregulate gene expression of neuroprotective molecules, including Oncostatin M (Osm) through a non-canonical Card9-independent pathway, mediated by NFAT. Furthermore, we found that the Osm receptor (OsmR) functions specifically in astrocytes to reduce EAE severity. Our study revealed a new mechanism of protective myeloid-astrocyte crosstalk regulated by a non-canonical Dectin-1 pathway and identifies novel therapeutic targets for CNS autoimmunity. Graphical AbstractO_LIDectin-1 is a protective C-type lectin receptor (CLR) in experimental autoimmune encephalomyelitis (EAE) C_LIO_LIDectin-1 promotes expression of Osm, a neuroprotective IL-6 family cytokine, in myeloid cells C_LIO_LIOsmR signaling in astrocytes limits EAE progression and promotes remission C_LIO_LINon-canonical Card9-independent signaling drives a distinct Dectin-1-mediated transcriptional program to induce expression of Osm and other factors with protective or anti-inflammatory functions C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=166 SRC="FIGDIR/small/080481v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@885aa2org.highwire.dtl.DTLVardef@1f68087org.highwire.dtl.DTLVardef@70263aorg.highwire.dtl.DTLVardef@ddc3b4_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology

α-Synuclein strains that cause distinct pathologies differentially inhibit proteasome

Abnormal -synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether differences in the strains of -synuclein aggregates account for the different pathologies remained unclear. Here, we generated two types of -synuclein fibrils from identical monomer and investigated their seeding and propagation ability in mice and primary-cultured neurons. One -synuclein fibril induced marked accumulation of phosphorylated -synuclein and ubiquitinated protein aggregates, while the other did not, indicating the formation of -synuclein two strains. Notably, the former -synuclein strain inhibited proteasome activity and co-precipitated with 26S proteasome complex. Further examination indicated that structural differences in the C-terminal region of -synuclein strains lead to different effects on proteasome activity. These results provide a possible molecular mechanism to account for the different pathologies induced by different -synuclein strains.

neuroscience